Loading provider…
Loading provider…
Cardiovascular Disease Physician in Norristown, PA
NPI: 1235103409Primary Employer
Cardiology Consultants of Philadelphia, P.C.
ccpdocs.com
HQ Phone
Get MD Gary's Phone Numberphone_androidMobile
Get MD Gary's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
Stromal expression of miR-21 identifies high-risk group in triple-negative breast cancer.
Authors: MacKenzie, Todd A, Schwartz, Gary N, Calderone, Heather M, Graveel, Carrie R, Winn, Mary E, Hostetter, Galen, Wells, Wendy A, Sempere, Lorenzo F
Journal: Am J Pathol
Publication Date: 2014-11-06
Personalized therapy for breast cancer.
Authors: De Abreu, F B, Schwartz, G N, Wells, W A, Tsongalis, G J
Journal: Clin Genet
Publication Date: 2014-04-09
Authors: Traphagen, Nicole A, Schwartz, Gary N, Tau, Steven, Roberts, Alyssa M, Jiang, Amanda, Hosford, Sarah R, Marotti, Jonathan D, Goen, Abigail E, Romo, Bianca A, Johnson, Anneka L, Duffy, Emily-Claire K, Demidenko, Eugene, Heverly, Paul, Mosesson, Yaron, Soucy, Shannon M, Kolling, Fred, Miller, Todd W
Journal: Clin Cancer Res
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, OTHER: Data Collection
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI), Seagen Inc.
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, DRUG: Placebo Administration, BIOLOGICAL: Trastuzumab Emtansine, DRUG: Tucatinib
Lead Sponsor: Dartmouth-Hitchcock Medical Center
Intervention / Treatment: DRUG: Exemestane, DRUG: Letrozole, DRUG: Anastrozole, DRUG: 17B-estradiol